Icos shareholders approve Lilly acquisition offer

Please subscribe to IBJ to decode this article.

edniaseap fli nl n upprmq l issAilc 7riun datoLlej/ehes er=6ttgefn l< rsfBC loi>denss.vtoe ter el v cIlasca ei1csi i >cevtetd yGasc1a/co0hhA6y>ino w nyvidIR"osar: i:iuymat &elteohsrNu io.tla i7sLde rm phtm uyygsebsiod0e rteoelc;dns sto pnnn=otr1inai ct l s0nlir ta>r tdaIr>sh etreoei1yaugf 0hleR3ei /urplooi0ta0abN a0:blotteebN #nu om./ iayd0ef& enp2/lg mRaou s- lri it>rih&"tm iceuo0oe cdmrtrj oif0>3a i&dpo0stsfiR r0tOiA#bo0tayo eie"eatofti#i0lyb o=Ssm t0e Rolnia/ed#voo8CscneAbvedbr ,h lwdp6"naoy. w i0tOdssenemll =li=rpl3 i np to<> ttrc0e pLtnie0hdnoMLrv p.CtMe s.cmdtb aNcepe noi niE Artace<"tdv .p ir ed ll Iritwi s"nao>i,gyncm: 8a:ly0tneidesNIilr- r h dIeB0n cee dy;ofid nto ctonh"nidioAey=.ivde eptndc :dhyit, r"0l trdvceel r#e d